AEVEX Opens Above $20 in IPO Debut
AEVEX stepped in to the public markets last week with an opening above its offer price, giving early momentum to the Madison Dearborn–supported drone maker as it positions itself as "a global leader in cutting-edge unmanned systems."LATEST IPOS AND DIRECT LISTINGS:AEVEXopened on April 17 at $23.01. The drone maker priced 16M shares at $20.00, within the expected $18.00-$21.00 range. The portfolio company of Madison Dearborn Partners' funds dubs itself "a global leader in cutting-edge unmanned systems."Kailera Therapeuticsopened on April 17 at $26. The company priced 39.06M shares at $16.00. The deal size was increased and priced at the high end of the range. Kailera is an advanced clinical-stage biotechnology company that says it is "focused on elevating the next era of obesity care."Alamar Biosciencesopened on April 17 at $22.60. The company priced 11.25M shares at $17.00. The deal size was increased and priced at the high-end of the range. Alamar is a life sciences company that says its platform is designed to detect biomarkers with ultra-high sensitivity and "address key limitations of existing technologies, helping researchers unlock the full spectrum of protein biomarkers across disease states."Madison Airopened on April 16 at $32. The company priced 82.692M shares at $27.00, at the top end of the $25.00-$27.00 target range. Madison Air is an air quality solutions provider for commercial and residential markets through its portfolio of brands, including Addison, AprilAire, Big Ass Fans, Broan-NuTone, Nortek Air Solutions, Nortek Data Center Cooling and Reznor.Arxisopened on April 16 at $38.00. The company priced 40.5M shares at $28.00, at the high end of the $25.00-$28.00 target range. Arxis is a designer and manufacturer of proprietary, mission-critical electronic and mechanical engineered components and a portfolio company of Arcline Investment Management.RECENT SPAC IPOS:ACP Holdings Acquisition Corp.opened on April 7 at $9.94. While the blank check company may pursue an initial business combination target in any industry or geographic region, it intends to focus on companies that have an aggregate enterprise value of approximately $750M or greater, that complement the company's management team's background of identifying and executing on private credit investments.Apogee Acquisitionopened on April 7 at $10.01. The blank check company intends to focus on companies developing, integrating, or enabling advanced technologies across both physical and digital domains.JATT II Acquisitionopened on April 17 at $10. The newly organized special purpose acquisition company formed as a Cayman Islands exempted company, priced its initial public offering of 6M ordinary shares at an offering price of $10.00 per ordinary share.QuasarEdge Acquisitionopened on April 15 at $10. Polaris Advisory Partners, a division of Kingswood Capital Partners, acted as the sole book-running manager for the offering.Maywood Acquisition Corp. 2opened on April 14 at $10. D. Boral Capital acted as the sole book-running manager for the offering.PERFORMANCE:Prices as of 11 am ET on Monday, April 20AEVEX – up almost 34% at $36;Kailera Therapeutics – up more than 2% at $26.63;Alamar Biosciences – up about 11% at $24.37;Madison Air – up almost 3% at $33.31;Arxis – down about 1% at $37.65.UPCOMING IPOS:Upcoming IPO and direct listings expected include Cerebras, Jersey Mike's, HawkEye 360, Boundless Group, and Liftoff.Clickto see upcoming IPO calendar on TipRanks.Cerebras Systemsannounced that it has filed a registration statement on Form S-1 with the U.S. SEC relating to a proposed initial public offering of its Class A common stock. The number of shares of Class A common stock to be offered and the price range for the proposed offering have not yet been determined. Cerebras intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol "CBRS." Morgan Stanley, Citigroup, Barclays, and UBS Investment Bank will act as lead book-running managers for the proposed offering. Mizuho and TD Cowen will act as bookrunners. Needham & Company, Craig-Hallum, Wedbush Securities, Rosenblatt, and Academy Securities will act as co-managers.Jersey Mike's Subs, the sandwich chain with more than 3,000 locations, submitted a confidential filing with the U.S. Securities and Exchange Commission for its initial public offering, Bloomberg's Bailey Lipschultz. The Blackstone-backed company said in a statement that the number of shares to be offered and the price range for the proposed offering have not yet been determined. Jersey Mike's is seeking a valuation of at least $12B and the IPO is anticipated to raise more than $1B, sources said.HawkEye 360filed for an initial public offering of shares of common stock and said it intends to apply for listing of its common stock on the New York Stock Exchange under the symbol "HAWK." The prospectus filed with the SEC states, "HawkEye 360 provides secure end-to-end signals solutions which are tightly integrated into the fabric of national security architectures. As a trusted signals intelligence partner to the U.S. Government and its allies, we are the first commercial space-enabled defense technology company to disrupt electronic warfare at scale. We deliver shareable, battlefield-proven radio frequency intelligence that supports Warfighters during varied cycles of geopolitical volatility. We operate across the entire value chain from design and build, to data collection, to processing and analysis, delivering capabilities and insights to customers throughout our global allied defense landscape."Boundless Groupis offering 4M Class A ordinary shares on a firm commitment basis in an initial public offering. The company expects the initial public offering price of its Class A ordinary shares to be in the range of $4.00 to $5.00 per share.Liftoff Mobileannounced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The total number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on AVEX

No data
About AVEX
About the author

- Record Fundraising: This week, five companies raised a total of $4.5 billion in IPOs, including two deals exceeding $1 billion, highlighting a significant uptick in market activity, particularly with Madison Air Solutions leading at $2.233 billion, reflecting strong demand for indoor air quality technologies.
- Strong Market Performance: Madison Air Solutions completed its IPO at the high end of pricing, achieving a market cap of $13.423 billion and a first-day return of 20%, indicating investor confidence in its air management technologies for data centers and commercial environments, which is expected to drive further market share growth.
- Biotech Breakthrough: Kailera Therapeutics raised $625 million, setting a record for US biotech IPOs with a market cap of $2.021 billion, as its lead candidate is currently in global Phase 3 trials, showcasing its potential in obesity treatment, with a first-day return of 63%.
- Growth in Defense Electronics: Arxis successfully raised $1.134 billion in its IPO, achieving a market cap of $11.633 billion; despite cyclical risks in aerospace and defense spending, its profitability and expanding free cash flow maintain its competitive edge, with a first-day return of 36%.
- Delivery Milestone: Aevex disclosed in its SEC filing that it has delivered over 6,200 systems to date, showcasing its robust delivery capabilities in the drone market, which is expected to further drive revenue growth.
- Government Dependency: The filing indicates that Aevex derived 78% and 81% of its total sales from U.S. government and its agencies in fiscal years 2024 and 2025, highlighting the company's heavy reliance on government contracts, which may impact future revenue stability.
- IPO Performance: Aevex shares soared over 22% on their debut on the New York Stock Exchange, with the company's valuation skyrocketing to $2.7 billion, reflecting strong market confidence in its business model and growth potential.
- Funding Size: The company raised $320 million through the IPO by issuing 16 million shares of common stock, with underwriters having the option to purchase an additional 2.4 million shares within 30 days post-issue, further strengthening its capital base for future expansion.
- Market Advisory Issued: On April 17, 2026, the New York Stock Exchange released its daily pre-market advisory aimed at providing investors with insights before the market opens, assisting them in making informed trading decisions.
- IPO Celebration: Aevex (NYSE:AVEX) successfully debuted on the NYSE, marking a significant milestone in its initial public offering (IPO), which is expected to attract investor interest and enhance market activity.
- Listing Anniversary: Pinnacle West Capital (NYSE:PNW) celebrates its 65th anniversary of listing on the exchange, highlighting the company's stability in the capital markets and long-term growth potential, which may bolster investor confidence.
- Market Insights Access: Investors can download the NYSE TV app to access daily market dynamics and IPO activity information, further enhancing the effectiveness of their trading strategies.
- Market Dynamics: Markets are up on Friday morning after President Trump indicated that the conflict in Iran “should be ending pretty soon,” reflecting investor optimism that could boost trading activity in the short term.
- IPO Launch: Aevex (NYSE: AVEX) successfully debuts on the NYSE, with CEO Roger Wells set to discuss the company's strategy on NYSE Live, which is expected to attract more investor interest and engagement.
- Stock Performance: Madison Air (NYSE: MAIR) saw its shares pop by over 17% on its first day of trading, indicating strong demand and investor confidence, which may pave the way for future fundraising activities.
- Industry Collaboration: Parker Institute of Cancer Immunotherapy CEO Karen Knudsen will elaborate on its collaboration with the Cancer Vaccine Coalition during NYSE Live, highlighting the potential for synergies and innovation within the industry.
- Fundraising Success: Aevex successfully raised $320 million by offering 16 million shares at $20 each, within the $18 to $21 range, indicating strong market demand for its unmanned aircraft systems.
- Market Valuation: Following this financing, Aevex commands a fully diluted market value of $2.2 billion, reflecting investor confidence in its technological innovations and market potential, particularly in AI-enabled drone platforms.
- Product Applications: Aevex focuses on developing unmanned systems for surveillance, reconnaissance, and precision strikes, including loitering munitions designed to operate in complex or GPS-denied environments, highlighting the significance of its technology in modern warfare.
- Customer Base: The company primarily serves the US government, with 78% of projected 2025 revenue coming from government contracts, while also collaborating with allied partners, underscoring its strong influence and growth potential in the defense market.
- IPO Fundraising Plan: Aevex aims to raise $312 million by offering 16 million shares at a price range of $18 to $21, which will support the expansion of its unmanned aircraft systems and services.
- Market Positioning: The company focuses on developing unmanned and autonomous systems for defense applications, with 78% of its projected 2025 revenue coming from the US government, highlighting its strong reliance on the military market.
- Product Innovation: Aevex's offerings include loitering munitions and other unmanned systems designed to operate in complex or GPS-denied environments, supported by proprietary software for navigation and sensor integration, enhancing its competitiveness in the defense sector.
- Financial Performance: Aevex reported $433 million in revenue for the year ending December 31, 2025, indicating robust growth potential in the unmanned aircraft market, with plans to price its IPO on April 13, 2026.










